Skip to main content
. 2021 Mar 4;2021(3):CD010172. doi: 10.1002/14651858.CD010172.pub3

ChiCTR1900020826.

Study name A multicenter randomized controlled clinical trial for standardized respiratory support treatment for acute severe virus pneumonia
Methods RCT, parallel‐group design. Multicentre study
Participants Estimated number of participants: 160
Setting: China
Inclusion criteria: age > 18 years; acute viral pneumonia
Exclusion criteria: indication for intubation and MV; received MV; hypercapnia; acute attack of bronchial asthma; acute exacerbation of COPD or other chronic lung diseases; cardiogenic pulmonary oedema; severe neutropenia; haemodynamic instability; GCS <= 12; contraindications to NIV; facial or nasal deformities, nasal deformities; requires airway protection; tracheotomy; refuses endotracheal intubation; pregnancy
Interventions Intervention group (HFNC)
Control group (NIV)
Outcomes All outcomes reported: intubation rate; time to intubation
Outcomes relevant to this review: intubation rate
Starting date 20 January 2019
Contact information Liu Xiaoqing, lxq1118@126.com. Xi Yin, xiyin86@163.com
Notes